🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/10/2002 | 51,15 | 51,99 | 50,70 | 51,76 | +1,48% | 2,54% | 5.663.497 |
| 29/10/2002 | 51,19 | 52,30 | 50,11 | 51,00 | -1,44% | 4,27% | 7.656.688 |
| 28/10/2002 | 51,91 | 52,71 | 51,36 | 51,75 | +2,49% | 2,61% | 12.329.930 |
| 25/10/2002 | 48,18 | 50,55 | 47,82 | 50,49 | +4,79% | 5,66% | 6.544.236 |
| 24/10/2002 | 49,11 | 49,57 | 47,76 | 48,18 | -1,69% | 3,69% | 6.012.690 |
| 23/10/2002 | 47,69 | 49,06 | 47,43 | 49,01 | +1,40% | 3,40% | 7.088.148 |
| 22/10/2002 | 48,09 | 48,57 | 47,49 | 48,33 | -0,98% | 2,24% | 6.047.798 |
| 21/10/2002 | 47,09 | 49,11 | 47,00 | 48,81 | +0,24% | 4,48% | 8.224.494 |
| 18/10/2002 | 48,43 | 48,85 | 46,85 | 48,69 | +0,55% | 4,12% | 11.185.828 |
| 17/10/2002 | 48,86 | 48,89 | 47,83 | 48,43 | +1,70% | 2,17% | 6.491.312 |
| 16/10/2002 | 48,62 | 49,24 | 47,15 | 47,61 | -1,93% | 4,30% | 7.044.761 |
| 15/10/2002 | 48,28 | 48,68 | 47,81 | 48,55 | +2,58% | 1,80% | 9.736.339 |
| 14/10/2002 | 45,14 | 47,99 | 45,14 | 47,33 | +4,86% | 6,30% | 9.880.125 |
| 11/10/2002 | 43,90 | 45,52 | 43,64 | 45,13 | +2,80% | 4,30% | 5.636.982 |
| 10/10/2002 | 43,54 | 44,13 | 42,40 | 43,90 | +0,83% | 3,99% | 9.122.840 |
| 09/10/2002 | 42,46 | 44,79 | 41,36 | 43,54 | -0,80% | 8,07% | 12.833.808 |
| 08/10/2002 | 42,94 | 44,66 | 42,59 | 43,89 | +4,24% | 4,82% | 7.907.789 |
| 07/10/2002 | 42,33 | 44,04 | 41,94 | 42,11 | -0,29% | 4,96% | 6.666.538 |
| 04/10/2002 | 43,71 | 43,89 | 41,77 | 42,23 | -4,39% | 4,87% | 8.416.698 |
| 03/10/2002 | 44,70 | 45,94 | 43,67 | 44,17 | -1,41% | 5,06% | 6.522.123 |
| 02/10/2002 | 44,80 | 45,68 | 44,42 | 44,80 | +1,23% | 2,81% | 6.852.348 |
| 01/10/2002 | 44,18 | 44,37 | 43,23 | 44,26 | +1,47% | 2,57% | 9.034.284 |
| 30/09/2002 | 44,14 | 44,32 | 43,05 | 43,62 | -1,19% | 2,88% | 7.777.942 |
| 27/09/2002 | 45,71 | 46,28 | 43,94 | 44,14 | -5,11% | 5,11% | 7.951.176 |
| 26/09/2002 | 45,52 | 46,52 | 45,31 | 46,52 | +2,20% | 2,64% | 6.995.190 |
| 25/09/2002 | 44,18 | 45,80 | 44,09 | 45,52 | +3,92% | 3,87% | 6.686.135 |
| 24/09/2002 | 42,61 | 44,11 | 42,40 | 43,80 | +1,44% | 4,01% | 6.743.356 |
| 23/09/2002 | 42,99 | 43,65 | 42,76 | 43,18 | -1,07% | 2,06% | 5.589.718 |
| 20/09/2002 | 43,11 | 43,98 | 43,11 | 43,65 | +1,22% | 2,01% | 10.351.306 |
| 19/09/2002 | 43,96 | 44,75 | 43,01 | 43,12 | -3,97% | 3,97% | 5.852.137 |